Two Tennessee sisters who rely on a full‑spectrum CBD oil to manage dystonia say the medicine that keeps them moving is suddenly a lot harder to find. They told WBIR that the oil eases pain and improves mobility, and that the same products that once arrived quietly on their doorstep are now disappearing from online catalogs or blocked from shipping into the state. Their struggle highlights a growing gap between Tennessee’s new hemp rules and the people who treat hemp‑derived products as part of their everyday medical routine.
What the law changes
In May 2025, the legislature passed SB1413/HB1376, enacted as Public Chapter 526, which overhauls how hemp‑derived cannabinoid products are defined, tested, and sold. As detailed in the bill text on the Tennessee General Assembly website, the law tightens the category of lawful hemp products, excludes THCa and many synthetic cannabinoids, and requires that products contain no more than 0.3 percent total THC on a dry‑weight basis. It also hands the Alcoholic Beverage Commission authority to license suppliers, wholesalers, and retailers under this new framework.
How oversight and sales will shift
Regulatory control over these products moved from the Department of Agriculture to the Tennessee Alcoholic Beverage Commission on January 1, 2026, and the commission has issued guidance spelling out what that means in practice. According to the Tennessee Alcoholic Beverage Commission, hemp‑derived cannabinoid products must now be sold only at age‑gated, licensed locations, stored behind barriers, and backed by batch‑level lab testing with a Certificate of Analysis. Direct‑to‑consumer shipping or delivery is no longer lawful. State tax guidance also creates a new wholesale levy and brand‑registration rules that could reshape pricing and availability for shoppers, per the Tennessee Department of Revenue.
Families say access is shrinking.
The sisters told WBIR they once ordered their preferred full‑spectrum oil online and had it shipped directly to their home. Now, they say, sellers are dropping certain products or refusing to send them into Tennessee at all. For patients who rely on steady, documented dosing and who already struggle with mobility, being pushed into in‑person, 21‑and‑up retail settings can feel like a major new hurdle. Their story shows how rules meant to curb intoxicating hemp products can ripple through households that view these oils as therapeutic tools, not recreational experiments.
Why do some patients prefer full‑spectrum
Dystonia is a neurological movement disorder that causes involuntary, often painful muscle contractions and can interfere with everyday activities, according to the Mayo Clinic. Some people with movement disorders report symptom relief from full‑spectrum hemp extracts that contain multiple cannabinoids along with trace amounts of THC, though clinical studies are still limited and results vary from person to person, as summarized in reviews on PubMed Central. Because product composition can differ dramatically from one bottle or batch to the next, clinicians and regulators advise keeping original packaging and batch Certificates of Analysis so patients and providers know exactly what was used, as the Tennessee Alcoholic Beverage Commission requires.
Retail and industry reaction
Business owners and industry groups warn that the overhaul could devastate shops that built their business on higher‑THCa flower and synthetic‑cannabinoid products. The Nashville Scene reported that some retailers describe the law as a near‑total reset of the market. The Chattanooga Times Free Press noted that lawmakers were told THCa flower accounts for a major share of sales at many hemp shops, which helps explain why store owners are nervous about what comes next.
Legal implications
The statute establishes both criminal and civil penalties for getting the new rules wrong. Selling or distributing hemp‑derived cannabinoid products without a license or to buyers under 21 is classified as a Class A misdemeanor, and the law explicitly prohibits direct shipments and delivery to consumers, with civil fines that escalate for repeat violations. It also forbids manufacturing or selling hemp products that contain THCa above very narrow trace thresholds or that exceed the 0.3 percent total‑THC cap. The enforcement and penalty sections are detailed in the bill text on the Tennessee General Assembly website.
What can patients do?
Patients who depend on hemp‑derived products are encouraged to talk with their clinician about options, including what to do if a favorite brand or formula disappears from shelves. Keeping product packaging and Certificates of Analysis can help providers track exactly what a patient has been using. State agencies are maintaining public guidance as the rules continue to roll out, and the Tennessee Department of Agriculture offers an overview for hemp industry participants. For more details on how families are navigating the changes on the ground, see coverage from WBIR.
